Pharma Journalist -

CStone Pharmaceuticals and Numab Therapeutics AG announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a…
Read More...

Tmunity Therapeutics announced that it has entered into an exclusive licensing and research collaboration with the University of California San Francisco (UCSF) aimed at advancing novel…
Read More...

SMi reports: There are two post-conference workshops taking place on the 5th June 2019, which will explain lyophilisation in its most simplistic terms. SMi’s 7th annual…
Read More...

PolyProx Therapeutics, a new biotechnology company focused on the discovery and development of novel biopharmaceuticals for the treatment of cancer, announced that it has raised £3.4m…
Read More...

AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic…
Read More...

Sandoz, a Novartis division and a global leader in biosimilars, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This medicine is…
Read More...

Ophthalmic sensors and digital health company Implandata Ophthalmic Products GmbH (Implandata) announced that it successfully attained CE mark for its EYEMATE system for use in patients…
Read More...

Hear Edmond Israelski (Abbott Laboratories), Lin Li (Eli Lilly) and Diane Doughty (MedImmune) discuss improving patient centricity through digital health at the Prefilled Syringes West…
Read More...

SMi’s 2nd annual Injectable Drug Delivery Conference will take place at the Copthorne Tara Hotel, Kensington, London, on the 15th – 16th May 2019. Here is a snapshot of key topics…
Read More...

EirGenix, Inc. announced that it has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, granting an exclusive license to Sandoz for right…
Read More...